FDA product code QSK: Hybrid Stent Graft, Thoracic Aortic Lesion Treatment

QSK is the FDA product code for hybrid stent graft, thoracic aortic lesion treatment. It is a Class III device, reviewed by the Cardiovascular panel. Devices under QSK reach the market by PMA; FDA lists no cleared 510(k)s for it. 2 PMA applications cite this product code.

Definition

Repair or replacement of damaged or diseased vessel of the aortic arch and descending thoracic aorta, with or without involvement of ascending aorta, using vascular grafts and/or stent grafts placed during open surgical repair.

Classification

FieldValue
Device nameHybrid Stent Graft, Thoracic Aortic Lesion Treatment
Device classClass III
Review panelCV — Cardiovascular
Medical specialtyUnknown
Premarket routePMA
ImplantYes
Life-sustaining or supportingYes

Recalls for QSK devices

FDA recall records list no recalls for product code QSK.

Frequently asked questions

What is FDA product code QSK?

QSK is the FDA product code for hybrid stent graft, thoracic aortic lesion treatment. It is a Class III device, reviewed by the Cardiovascular panel.

What device class is QSK?

Class III. Typical premarket route: PMA.

Next steps

Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.

All Cardiovascular product codes · FDA product code lookup · 510(k) database search · 510(k) review times